Stock Quote Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cytek Biosciences Inc (NQ: CTKB ) 9.350 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Mar 21, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 9.350 Bid (Size) 8.000 (10) Ask (Size) 9.800 (200) Prev. Close 9.350 Today's Range 9.350 - 9.350 52wk Range 7.380 - 16.05 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year Top News More News Cytek® Biosciences Introduces New 20-Color AML Panel March 07, 2023 Optimized for Cytek Cell Analysis Systems; Single-Tube Panel Accelerates Acute Myeloid Leukemia Research and MRD Detection From Cytek Biosciences, Inc. Via Globe NewsWire 12 Health Care Stocks Moving In Friday's After-Market Session March 03, 2023 Via Benzinga Performance YTD -7.61% -7.61% 1 Month -14.77% -14.77% 3 Month -7.97% -7.97% 6 Month -28.46% -28.46% 1 Year -17.69% -17.69% More News Read More Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results February 28, 2023 From Cytek Biosciences, Inc. Via Globe NewsWire Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed February 28, 2023 From Cytek Biosciences, Inc. Via Globe NewsWire Cytek Biosciences Acquires Flow Cytometry & Imaging Business From DiaSorin February 14, 2023 Via Benzinga Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 14, 2023 Via Benzinga Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin February 13, 2023 From Cytek Biosciences, Inc. Via Globe NewsWire Cytek Biosciences Earnings Perspective: Return On Capital Employed December 15, 2022 Via Benzinga Recap: Cytek Biosciences Q2 Earnings August 10, 2022 Via Benzinga Earnings Preview: Cytek Biosciences August 09, 2022 Via Benzinga Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 February 07, 2023 From Cytek Biosciences, Inc. Via Globe NewsWire Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios February 07, 2023 From Cytek Biosciences, Inc. Via Globe NewsWire Cytek Biosciences to Participate in Upcoming Investor Conferences February 06, 2023 From Cytek Biosciences, Inc. Via Globe NewsWire Oak Street Health, PriceSmart And Some Other Big Stocks Moving Higher In Tuesday's Pre-Market Session January 10, 2023 Via Benzinga 5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More December 15, 2022 Via Benzinga Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference November 21, 2022 From Cytek Biosciences, Inc. Via Globe NewsWire Cytek® Biosciences Introduces Cytek Cloud November 15, 2022 From Cytek Biosciences, Inc. Via Globe NewsWire Cytek Biosciences Reports Third Quarter 2022 Financial Results November 09, 2022 From Cytek Biosciences, Inc. Via Globe NewsWire Earnings Outlook For Cytek Biosciences November 08, 2022 Via Benzinga Cytek® Biosciences Names Chris Williams Chief Operating Officer October 31, 2022 From Cytek Biosciences, Inc. Via Globe NewsWire Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022 October 26, 2022 From Cytek Biosciences, Inc. Via Globe NewsWire Cytek to Participate in the 31st Annual Credit Suisse Healthcare Conference October 26, 2022 From Cytek Biosciences, Inc. Via Globe NewsWire Pinterest, Perion Network And Some Other Big Stocks Moving Higher In Today's Pre-Market Session October 06, 2022 Via Benzinga Piper Sandler Maintains Overweight Rating for Cytek Biosciences: Here's What You Need To Know August 18, 2022 Via Benzinga Analyst Ratings for Cytek Biosciences August 12, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
